Thrombosis and Haemostasis

LinksSchließen

Referenz

Chi G, Yee MK, Amin AN. , et al.
Extended-duration betrixaban reduces the risk of rehospitalization associated with venous thromboembolism among acutely ill hospitalized medical patients: findings from the APEX trial (acute medically ill venous thromboembolism prevention with extended duration betrixaban trial).

Circulation 2018;
137 (01) 91-94

Bibliographische Angaben herunterladen

Aufrufen in: